GNPX peer analysis
Genprex (GNPX) against its competitors: price, today's move, 1-year return and market value side by side.
- GNPX's peers: BDRX (Biodexa Pharmaceuticals), BIVI (BioVie), CMMB (Chemomab), CNSP (CNS Pharmaceuticals), GRI (GRI Bio), INM (InMed Pharmaceuticals), JAGX (Jaguar Health), LIMN (Liminatus Pharma).
GNPX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDRX Biodexa Pharmaceuticals | $1.95 | -2.26% | -98.74% | $181.86K |
| BIVI BioVie | $0.80 | -12.07% | -41.61% | $8.58M |
| CMMB Chemomab | $1.14 | -26.45% | -57.78% | $9.18M |
| CNSP CNS Pharmaceuticals | $3.92 | -11.82% | -41.57% | $5.78M |
| GRI GRI Bio | $1.12 | -11.81% | -97.63% | $2.45M |
| INM InMed Pharmaceuticals | $15.56 | 17.79% | 812.61% | – |
| JAGX Jaguar Health | $0.22 | -32.42% | -99.97% | $2.95M |
| LIMN Liminatus Pharma | $2.81 | 4.85% | -94.98% | $188.72M |
| TOVX Theriva Biologics | $0.13 | -11.11% | -44.42% | $5.87M |
| GNPX Genprex | $1.67 | -2.34% | -97.73% | $843.24K |